http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103122000-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77a6f483872afe160cd0ca235fdd5045
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 2012-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9c40f66f221f58c0a31c89b81ca4894
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60472b9462d48c3384331063c8a4ad21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81d6ba87195714be60f66e3076bd5dc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c119470896cf6235532041a5ecfd11f5
publicationDate 2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103122000-A
titleOfInvention Highly Selective c-Met Kinase Inhibitors Used as Antineoplastic Drugs
abstract The present invention relates to a compound of formula I and pharmaceutically acceptable salts thereof, wherein A, Ar, E, G, J, M, R 1 , R 2 , R 3 , X and X 1 are as defined in the description. The invention also relates to pharmaceutical compositions containing these compounds, processes for their preparation and their use in the preparation of medicaments for the treatment of cancer. Formula I
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109206357-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105326793-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106924260-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017114249-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180095093-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108853108-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113105436-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113105436-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400088-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106924260-A
priorityDate 2012-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102015716-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412133476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID144581343
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118274591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164016713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163436897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID52142099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465168498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465815680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467484055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID464979883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431658903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467333578

Total number of triples: 51.